NorthStar Cryo believes that disruptive innovation in cryopreservation will unlock the potential of regenerative cell therapy. CryoMesh, our core platform for vitrification of cellular systems, enables effective deployment of game-changing and life altering cell therapies at the right time, in the right place and in the right quantity.
Learn more about the science behind and the potential of CryoMesh in these publications:
● Pancreatic islet cryopreservation by vitrification achieves high viability, function, recovery and clinical scalability for transplantation – Zhan et al., Nature Medicine, Vol. 28, pages 798–808 (2022)
● Conduction-Dominated Cryomesh for Organism Vitrification – Guo et al., Advanced Science, Vol 11, Issue 3 (2024)
● Cryopreservation methods for Drosophila melanogaster embryos – Nature Communications, 12, Article number: 2412 (2021)
● Vitrification and nanowarming enable long-term cryopreservation and life-sustaining kidney transplantation in a rat model – Han et al., Nature Communications, Vol. 14, Article number: 3407 (2023)
Company Details
- Employees
- 2
- Founded
- -
- Address
- Minneapolis, Mn, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Minneapolis, MN
Northstar Cryo Questions
Northstar Cryo's LinkedIn profile is https://www.linkedin.com/company/northstarcryo
Northstar Cryo has
2 employees.
View email and phone details for 2
employees at Northstar Cryo.
Northstar Cryo's industry is
Biotechnology Research
Northstar Cryo's top competitors are
Echo Data Analytics,
Gennext Turf,
Wavecyte Biolabs,
Gavia Bio, Llc,
Ribolexi, A Life Sciences Translation Company,
Celcuity,
Dolore Biotechnology Llc,
Zepto Life Technology,
Biosakura,
Botech L.l.c..
Northstar Cryo's categories are Biotechnology Research
Northstar Cryo's founding year is 2024
